Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis

Annals of the Rheumatic Diseases

Volumn 66, Issue 10, 2007, Pages 1384-1387

  Heijstek, Marloes W ^a   Pileggi, Gecilmara C S ^a,b   Zonneveld Huijssoon, Evelien ^a   Armbrust, Wineke ^c   Hoppenreijs, Esther P A H ^d   Uiterwaal, Cuno S P M ^e   Kuis, Wietse ^a   Wulffraat, Nico M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; MEASLES MUMPS RUBELLA VACCINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFECT; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALAISE; MEASLES; MUMPS; PRIORITY JOURNAL; RASH; RUBELLA; VACCINATION;

ADMINISTRATION, ORAL; ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; HUMANS; MEASLES-MUMPS-RUBELLA VACCINE; METHOTREXATE; RETROSPECTIVE STUDIES; VACCINATION;

EID: 34249293124     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.063586     Document Type: Article

References (19)

1. Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet 2003;362:1659-66.
2. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity - 'vaccinosis': a dangerous liaison? J Autoimmun 2000;14:1-10.
3. Benjamin CM, Chew GC, Silman AJ. Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine. BMJ 1992;304:1075-8.
4. Zonneveld-Huijssoon E, Ronaghy A, Rossum van M, Rijkers GT, Klis van der F, Sanders E, et al. Safety and efficacy of meningococcal C vaccination in juvenile idiopathic arthritis. Arthritis Rheum 2007; doi:10.1136/ard.2006.063586.
5. Kasapcopur O, Cullu F, Kamburoglu-Goksel A, Cam H, Akdenizli E, Calykan S, et al. Hepatitis B vaccination in children with juvenile idiopathic arthritis. Ann Rheum Dis 2004;63:1128-30.
6. Malleson PN, Tekano JL, Scheitele DW, Weber JM. Influenza immunization in children with chronic arthritis: a prospective study. J Rheumatol 1993;20:1769-73.
7. Howson CP, Katz M, Johnston RB Jr, Fineberg HV. Chronic arthritis after rubella vaccination. Clin Infect Dis 1992;15:307-12.
8. Ray P, Black S, Shinefield H, Dillon A, Schwalbe J, Holmes S, et al. Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team. JAMA 1997;278:551-6.
9. Inspectorate for Dutch Health Care. Vaccination situation in the Netherlands per January 2002 (abstract in English). The Hague: Inspectorate for Dutch Health Care, 2004.
10. BSR Clinical Affairs Committee. Vaccinations in the immunocompromised person: guidelines for the patient taking immunosuppressants, steroids and the new biologic therapies London: British Society for Rheumatology. 2006.
11. Update: multistate outbreak of mumps - United States, January 1-May 2, 2006. MMWR Morb Mortal Wkly Rep 2006;55:559-63.
12. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
13. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
14. Len C, Ferraz MB, Goldenberg J, Oliveira LM, Araujo PP, Quaresma MR, et al. Pediatric Escola Paulista de Medicina Range of Motion Scale: a reduced joint count scale for general use in juvenile rheumatoid arthritis. J Rheumatol 1999;26:909-13.
15. Brunner HI, Lovell DJ, Finck BK, Giannini EH. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol 2002;29:1058-64.
16. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81.
17. Andersson GB, Fasth A, Andersson J, Berglund G, Ekstrom H, Eriksson M, et al. Incidence and prevalence of juvenile chronic arthritis: a population survey. Ann Rheum Dis 1987;46:277-81.
18. Peterson LS, Mason T, Nelson AM, O'Fallon WM, Gabriel SE. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing? Arthritis Rheum 1996;39:1385-90.
19. Magni-Manzoni S, Cugno C, Pistorio A, Garay S, Tsitsami E, Gasparini C, et al. Responsiveness of clinical measures to flare of disease activity in juvenile idiopathic arthritis. Clin Exp Rheumatol 2005;23:421-5.